Skip to content

A study to evaluate the efficacy of Balaguduchyadi basti on the level of micronutrients.

Clinical study to evaluate the efficacy of Balaguduchyadi basti on the level of Micronutrients.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056473
Enrollment
48
Registered
2023-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R70-R79- Abnormal findings on examination of blood, without diagnosis Health Condition 2: K00-K95- Diseases of the digestive system Health Condition 3: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with any of micronutrient deficiency- Vit D, Iron, Calcium, Vit B-12, Magnesium,Zinc, Folic Acid- Requiring any External panchakarma therapy, Independent of Sex, eating habits or socio- economic status

Exclusion criteria

Exclusion criteria: Patients who are contraindicated for niruha basti and anuvasan basti like skin disorders, ascites, intestinal perforation ,intestinal obstruction etc. will not be included in the trial (Group A) Patients with comorbid condition such as hypertension(systolic >150mmhg and diastolic >100 mmhg despite anti hypertensive medication) and diabetes mellitus (having HBA1c >7%) despite anti diabetic medication) Pregnant women and lactating mothers Patient suffering from major illness such as malignancy, HIV and TB Patient requiring emergency treatment

Design outcomes

Primary

MeasureTime frame
Assessment of the effect of basti on objective parameters of Vitamin D, Vitamin B12, Serum iron, Serum zinc, Serum calcium, Serum magnesium, and Serum folic acid. Timepoint: Vitamin D, Vitamin B12, Serum iron, Serum zinc, Serum calcium, Serum magnesium, and Serum folic acid. [Time frame:45th day]

Secondary

MeasureTime frame
1.Assessment of quality of life using the questionnaire of WHO - QOL BREF Scale. 2.Assessment of absorption of Balaguduchyadi basti in the systemic circulation.Timepoint: 1.Questionnaire of WHO-QOL Bref Scale.[Time frame:45th day] 2.HPLC [Time frame: between 1st to 2nd day]

Countries

India

Contacts

Public ContactDrRohit Pal

Ayurvedic and Unani Tibbia College and Hospital

nitjin2005@gmail.com9811765501

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026